+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

From
Targeted Oncology Therapeutics: Lung Cancers - Product Thumbnail Image

Targeted Oncology Therapeutics: Lung Cancers

  • Report
  • October 2021
  • 82 Pages
  • Global
From
NASH Treatment & Therapeutics Market Report 2023-2033 - Product Thumbnail Image

NASH Treatment & Therapeutics Market Report 2023-2033

  • Report
  • July 2023
  • 224 Pages
  • Global
From
From
From
Global and China Monoclonal Antibody Industry Report, 2019-2025 - Product Thumbnail Image

Global and China Monoclonal Antibody Industry Report, 2019-2025

  • Report
  • April 2019
  • 180 Pages
  • Global, China
From
From
Alzheimer's Drugs Global Market Report 2024 - Product Thumbnail Image

Alzheimer's Drugs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Royalty Rates in Pharmaceutical and Biotechnology Deals - Product Thumbnail Image

Royalty Rates in Pharmaceutical and Biotechnology Deals

  • Report
  • August 2024
  • 500 Pages
  • Global
From
From
From
From
Unresectable Hepatocellular Carcinoma Global Market Report 2024 - Product Thumbnail Image

Unresectable Hepatocellular Carcinoma Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
Loading Indicator